Urology 2014-07-01

Multi-institutional 1-year bulbar urethroplasty outcomes using a standardized prospective cystoscopic follow-up protocol.

Bradley A Erickson, Sean P Elliott, Bryan B Voelzke, Jeremy B Myers, Joshua A Broghammer, Thomas G Smith, Chris D McClung, Nejd F Alsikafi, William O Brant

Index: Urology , doi:10.1016/j.urology.2014.01.054, (2014)

Full Text: HTML

Abstract

To evaluate multi-institutional outcomes of bulbar urethroplasty utilizing a standardized cystoscopic follow-up protocol.Eight reconstructive surgeons prospectively enrolled urethral stricture patients in a multi-institutional study and performed postoperative cystoscopy at 3 and 12 months. Anatomic failure was defined as the inability to pass a flexible cystoscope without force. Functional failure was defined as the need for a secondary procedure. Men not compliant with the 12-month cystoscopy were called and asked if any interval secondary procedures had been performed. Patients with bothersome voiding complaints at cystoscopy were considered symptomatic.Of 213 men in study, 136 underwent excisional urethroplasty (excision and primary anastomosis [EPA]) and 77 underwent repair with buccal grafts. Cystoscopy compliance was 79.8% at 3 months and 54.4% at 12 months. Anatomic success rates were higher at 3 vs 12 months for EPA repairs (97.2% [106 of 109] vs 85.5% [65 of 76; P=.003] but not buccal repairs (85.5% [53 of 62] vs 77.5% [31 of 40]; P=.30). Functional success rates at a year were higher but statistically similar to anatomical success rates (EPA-90.3% [93 of 103]; P=.33; buccal-87% [47 of 54]; P=.22). Of the 20 anatomic recurrences, only 13 (65%) were symptomatic at the time of cystoscopic diagnosis.Rates of success are lower when using the anatomic vs traditional definition. Of recurrences found by cystoscopy, only 65% were symptomatic. One-year patient cystoscopy compliance was poor and its ability to be used as the gold standard screening methodology for recurrence is questionable.Copyright © 2014 Elsevier Inc. All rights reserved.


Related Compounds

Related Articles:

WIN OVER study: Efficacy and safety of olmesartan in Indian hypertensive patients: results of an open label, non-comparative, multi-centric, post marketing observational study.

2014-01-01

[Indian Heart J. 66(3) , 340-344, (2014)]

Feasibility of cisplatin/5-fluorouracil and panitumumab in Japanese patients with squamous cell carcinoma of the head and neck.

2014-07-01

[Jpn. J. Clin. Oncol. , (2014)]

Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.

2014-11-01

[Br. J. Clin. Pharmacol. , doi:10.1111/bcp.12426, (2014)]

In-patient diabetes care: the impact of diabetes outreach team on long-term glycaemic control.

2014-11-01

[Int. J. Clin. Pract. , doi:10.1111/ijcp.12458, (2014)]

Traumatic subarachnoid hemorrhage due to motor vehicle crash versus fall from height: a 4-year epidemiologic study.

2014-11-01

[World Neurosurg. , doi:10.1016/j.wneu.2014.06.022, (2014)]

More Articles...